HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

((2R)- 2- ((1S)- 6,7- dimethoxy- 1- (2- (4- trifluoromethylphenyl)- ethyl)- 3,4- dihydro- 1H- isoquinolin- 2- yl)- N- methyl- 2- phenylacetamide)

a dual orexin receptor antagonist for treatment of insomnia
Also Known As:
ACT-078573; almorexant
Networked: 24 relevant articles (5 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hoever, Petra: 7 articles (05/2014 - 01/2011)
2. Dingemanse, Jasper: 7 articles (05/2014 - 01/2011)
3. Hoyer, Daniel: 4 articles (12/2013 - 12/2012)
4. Steiner, Michel A: 3 articles (04/2015 - 04/2013)
5. Jenck, Francois: 3 articles (04/2015 - 04/2013)
6. Jacobson, Laura H: 3 articles (12/2013 - 01/2013)
7. Fendt, Markus: 3 articles (10/2013 - 12/2012)
8. Gee, Christine E: 3 articles (10/2013 - 12/2012)
9. Gehin, Martine: 2 articles (05/2014 - 01/2014)
10. Cruz, Hans Gabriel: 2 articles (05/2014 - 01/2014)

Related Diseases

1. Sleep Initiation and Maintenance Disorders (Insomnia)
2. Sleep Disorders
3. Fatigue
4. Nervous System Diseases (Neurological Disorders)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. orexins (orexin)
2. Ketoconazole (Nizoral)
3. Sertraline (Zoloft)
4. Serotonin (5 Hydroxytryptamine)
5. Pilocarpine (Ocusert)
6. Cytochrome P-450 Enzyme System (Cytochrome P450)
7. des-n-octanoyl ghrelin
8. 1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl urea